• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Some medical device makers acquiesce to healthcare reform tax

Some medical device makers acquiesce to healthcare reform tax

November 12, 2009 By MassDevice staff

Some medical device makers are fighting tooth-and-nail against proposals to tax their industry to help pay for healthcare reform. But others, including one of the sector’s biggest players, say they understand that device makers must pay a share of healthcare reform’s estimated $900 billion tab.

Days after news broke that St. Jude Medical (SJM) was pulling out of AdvaMed in a dispute over the tax, the medical device industry’s national trade council chairman Michael Mussallem (also CEO of Edwards Lifesciences (EW)) said the industry accepts the tax idea, according to Reuters.

“We’re not huge fans of it, but I think at this point we very much believe that this is something that we need to do, that’s our contribution to healthcare reform to help pay for this big bill,” Mussallem said at the Reuters Health Summit in New York.

Those remarks came almost a month to the day after Mussallem, interviewing former President Bill Clinton at AdvaMed’s annual conference in Washington, said the tax would have “a pretty devastating impact” on the industry.

“We feel like we are creating innovations that really matter. We are creating jobs. And to some extent we are sort of killing the golden goose here. But we are struggling getting our message across,” Mussallem said, before asking Clinton for advice on how to better make the industry’s voice heard inside the Beltway.

“[M]y advice is simple. If you don’t like this, you need to go to the [Senate Finance Committee] and go to the Senate and make sure the conference committee knows exactly what is wrong with [the tax proposal] and why it would cost more over the long run, in retarding technology and quality of healthcare, than the benefits would be, and also suggest some other way for them to get the money,” Clinton said. “This should be an evidence-based opinion. … [I]f you look at the benefits that technologies have brought, in terms of lengthening quality and length of life, and in terms of reducing hospitalization, particularly, I think it ought to be fairly easy to figure out if there are some places where there are abusive selling practices and isolate them without tarring the whole industry.

“You ought to be able to make an unassailable case that medical technology has been a huge boon to American life and to the American economy. And then you ought to say to other people, ‘Where is your evidence that there have been abuses?’ Then, if the evidence is right, figure out how to fix that.”

Filed Under: Healthcare Reform Tagged With: Industry Council

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy